Key facts
- FDA issued warning letters to Medline Industries.
- Warnings relate to manufacturing issues at Medline's Illinois plant.
- Concerns focus on potential problems with production processes.
The U.S. Food and Drug Administration (FDA) has issued warning letters to Medline Industries. These letters address manufacturing issues identified at the company's facility located in Illinois. The concerns raised by the FDA specifically highlight potential problems within the production processes employed at this particular plant. The issuance of warning letters by the FDA signifies a formal notification of regulatory non-compliance and typically requires corrective actions from the company.